Overview

Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

Status:
Active, not recruiting

Trial end date:
2021-09-06

Target enrollment:

Participant gender:

Summary

To determine whether a heterologous vaccination regimen in individuals with no known previous history of COVID-19 is non-inferior to that observed with counterpart regimens currently in use in Argentina among persons aged 21 to 65 years

Phase:

Phase 2

Details

Lead Sponsor:

Ministerio de Salud de Ciudad Autónoma de Buenos Aires